Boston, MA 05/02/2014 (wallstreetpr) – One of the leading players in the pharmaceutical business, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) operates towards development of therapeutic products in the field of treatment of CNS disorders. Recently many actions have taken place in the Avanir’s front including series of announcements and lawsuits. The company is marking up towards development of a robust strategy for gaining desired results in the coming quarters.
Gearing up for Conferences
Recently Avanir has announced that the company is gearing up for participating in two of the prime conferences in the month of May. The company has announced the details of the same through a press release. Avanir has declared that the company will participate in – Firstly, Deutsche Bank 39th Annual Health Care Conference to b held on May 8, 2014 and Bank of America Merrill Lynch 2014 Health Care conference on May 13, 2014. The company will present a live webcast for 30 days that can be accessed via official website of the company.
Inclination of Lawsuits In Favor Of Avanir
Recently Avanir has announced that the U.S. District Court has ruled in favor of Avanir and against Impax Laboratories Inc (NASDAQ:IPXL) and Par Pharmaceuticals, Inc. related to patent infringement. The two contesting companies had filed ANDAs (Abbreviated New Drug Application) to obtain the generic visions of Avanir’s Nuedexta the rejection in favor of Avanir’s Nuedexta has helped in gaining exclusivity to the Avanir’s business. Avanir is looking forward towards expanding Nuedexta’s label in the U.S. and across the globe.
Announcement of dates for 2Q2014 results
Avanir recently announced the dates for the announcement of financial results of 2Q22014 results for the quarter ending on March 31, 2014. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) is scheduled to declare the result on May 6, 2014 after the close of market. Avanir has also declared to hold a conference call and audio webcast of the results at 1:30 pm on the same day. Further, Avanir will also hold a replay of the webcast on the official website for 30 days.
